Results 81 to 90 of about 714,630 (331)

Communicable Diseases [PDF]

open access: yes, 2000
Sanitation, food control, vaccines, and antibiotics have reduced the toll of communicable diseases, saving millions of lives. Smallpox was eradicated in 1977, and poliomyelitis eradication is close. Measles mortality has reduced drastically yet outbreaks occur where immunization lags.
Tulchinsky, Theodore H.   +1 more
openaire   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

NON COMMUNICABLE DISEASES

open access: yesPakistan Journal of Medicine and Dentistry
Non Communicable Diseases (NCD’s), the emerging of major cause of morbidity and mortality worldwide including developing countries, are estimated to accounts for 50% of total deaths in Pakistan according to WHO country profile of 2014.
Ejaz A Vohra
doaj  

Modelling prevention strategies in Public Health [PDF]

open access: yes, 2015
Various schemes of prevention measures in public health are developed and analyzed on the basis of a general mathematical model. Features related to cost issues, including primary and secondary prevention interventions, differential survival experiences
Parisi V., SCHINAIA, Giuseppe
core  

Editorial: Translational Research and Drug Repurposing for Non-Communicable Diseases (NCDs) [PDF]

open access: gold, 2022
Abidemi J. Akindele   +6 more
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Project vital: Community revitalization industry report [PDF]

open access: yes, 2018
ViTAL (Vitality Through Active Living) FIJIAN PROJECT The ViTAL project aims to aid in the reduction of non-communicable diseases (NCDs) through investment in the health and well-being of women by increasing the level of participation in physical ...
Longhurst, Glynis
core  

Molecular determinants of signal transduction in tropomyosin receptor kinases

open access: yesFEBS Open Bio, EarlyView.
Tropomyosin receptor kinases control critical neuronal functions, but how do the same receptors produce diverse cellular responses? This review explores the structural mechanisms behind Trk signaling diversity, focusing on allosteric modulation and ligand bias.
Giray Enkavi
wiley   +1 more source

Evaluating Innovative Health Programs: Lessons for Health Policy [PDF]

open access: yes
The Global Development Network’s (GDN) project “Evaluating Innovative Health Programs” (EIHP), funded by the Bill & Melinda Gates Foundation, seeks to inform policy on the effectiveness of health solutions that have the potential to improve health ...
Jones, Andrew M   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy